Mo1641 Efficacy and Tolerability of Linaclotide and Plecanatide in Treating Irritable Bowel Syndrome With Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC): A Meta-Analysis

Meta Analysis ◽

Idiopathic Constipation ◽

Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis

10.1038/ajg.2014.202 ◽

2014 ◽

Vol 109 (10) ◽

pp. 1547-1561 ◽

Cited By ~ 372

Author(s):

Alexander C Ford ◽

Eamonn M M Quigley ◽

Brian E Lacy ◽

Anthony J Lembo ◽

Yuri A Saito ◽

...

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Idiopathic Constipation ◽

Faculty Opinions recommendation of Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726266208.793516543 ◽

2016 ◽

Author(s):

Aldo Infantino

Keyword(s):

Systematic Review ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Idiopathic Constipation ◽

Randomized Controlled ◽

Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis

10.1038/ajg.2017.495 ◽

2018 ◽

Vol 113 (3) ◽

pp. 329-338 ◽

Cited By ~ 31

Author(s):

Eric D Shah ◽

Hyungjin Myra Kim ◽

Philip Schoenfeld

Keyword(s):

Systematic Review ◽

Guanylate Cyclase ◽

Meta Analysis ◽

Idiopathic Constipation ◽

Guanylate Cyclase C ◽

Faculty Opinions recommendation of Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.719105613.793516780 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Idiopathic Constipation ◽

Therapeutic Peptide ◽

Irritable Bowel ◽

Novel Therapeutic

Plecanatide in chronic idiopathic constipation and irritable bowel syndrome with constipation: a profile of its use in the USA

Drugs & Therapy Perspectives ◽

10.1007/s40267-018-0579-y ◽

2018 ◽

Vol 34 (12) ◽

pp. 554-559

Author(s):

Hannah A. Blair

Keyword(s):

Idiopathic Constipation ◽

The Usa ◽

Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation

10.14309/ajg.0000000000000530 ◽

2020 ◽

Vol 115 (4) ◽

pp. 596-602 ◽

Cited By ~ 2

Author(s):

Eric D. Shah ◽

Suraj Suresh ◽

Jessica Jou ◽

William D. Chey ◽

Ryan W. Stidham

Keyword(s):

Idiopathic Constipation ◽

Chronic Therapy ◽

S0517 Efficacy of Plecanatide in Bloated Patients With Chronic Idiopathic Constipation and Moderately to Severely Bloated Patients With Irritable Bowel Syndrome With Constipation

10.14309/01.ajg.0000704116.71086.b8 ◽

2020 ◽

Vol 115 (1) ◽

pp. S245-S246

Author(s):

Darren M. Brenner ◽

Amol Sharma ◽

Reema Patel ◽

Sarah Lorenzen ◽

Gregory S. Sayuk

Keyword(s):

Idiopathic Constipation ◽

A case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort

Journal of Medical Economics ◽

10.1080/13696998.2016.1253584 ◽

2016 ◽

Vol 20 (3) ◽

pp. 273-279 ◽

Cited By ~ 9

Author(s):

Linda M. Herrick ◽

William M. Spalding ◽

Yuri A. Saito ◽

James Moriarty ◽

Cathy Schleck

Keyword(s):

Healthcare Provider ◽

Medical Costs ◽

Case Control ◽

Community Based ◽

Idiopathic Constipation ◽

Control Comparison ◽

A National Survey and Needs Assessment on Choices of Therapeutic Agents for Chronic Idiopathic Constipation and Constipation Predominant Irritable Bowel Syndrome: A Canadian Perspective

10.14309/00000434-201510001-01782 ◽

2015 ◽

Vol 110 ◽

pp. S758

Author(s):

Yvonne Tse ◽

Louis WC. Liu ◽

Christopher Andrews ◽

David Armstrong

Keyword(s):

Needs Assessment ◽

National Survey ◽

Therapeutic Agents ◽

Idiopathic Constipation ◽

Canadian Perspective ◽

Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation

Expert Review of Gastroenterology & Hepatology ◽

10.1586/17474124.2.4.497 ◽

2008 ◽

Vol 2 (4) ◽

pp. 497-508 ◽

Cited By ~ 7

Author(s):

Richard Saad ◽

William D Chey

Keyword(s):

Idiopathic Constipation ◽